Browse diseases

…l (MMF), one of the most prescribed immunosuppressive agents in SLE, has been strongly associated with an increased risk of first t…

…An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more likely t…

…6 (p<0.05).Conclusion QJZG effectively improved renal injury in SLE by reducing inflammation and modulating the AMPK/ULK1 signallin…

…67/25.5±30.71; p=0.009).Conclusion Tofacitinib in patients with SLE with active MC manifestations showed good effectiveness by week…

…Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibr…

…fic lupus collaboration. definition and initial validation of a lupus low disease activity state (LLDAS). Ann Rheum Dis. 2016 Sep;75(…

…Lupus arthritis sometimes receives less attention than other manifestations of …

…lymphoma, from 1999 onwards they started treating patients with rheumatoid arthritis with this B-cell depleting agent. Its effectiveness was obvious…

…proven effective in B cell-mediated autoimmune diseases such as systemic sclerosis and systemic lupus erythematosus (SLE).Learning Objectives At t…

…Objective To identify factors associated with individual Systemic Lupus International Collaborating Clinics/American College of Rheumat…

…ent-experience research.Methods We extracted 4633 posts from 10 SLE-related Reddit communities using the public Reddit Application Programm…

…rogeneity for this population.Results A 51-year-old female with systemic lupus erythematosus vs undifferentiated connective tissue disorder on mycophenolate…